−0.814EUR
−8.24 MEUR
304.00 KEUR
3.04 M
About 4 SC AG KONV.
Sector
Industry
CEO
Jason Loveridge
Website
Headquarters
Planegg-Martinsried
Employees (FY)
15
Founded
2000
ISIN
DE000A3E5C40
FIGI
BBG000MXBWC6
4SC AG is a clinical-stage biopharmaceutical company, which engages in the development of small molecule drugs that target key indications in cancer. Its product pipeline includes resminostat and domatinostat. The company was founded by Stefan Busemann, Ulrich Dauer, Klaus-Peter Gulden, and Daniel Vitt in 1997 and is headquartered in Planegg-Martinsried, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange 4 SC AG KONV. stocks are traded under the ticker VSC.
4 SC AG KONV. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track 4 SC AG KONV. financials in yearly and quarterly reports right on TradingView.
Like other stocks, VSC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4 SC AG KONV. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 15.00 employees. See our rating of the largest employees — is 4 SC AG KONV. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4 SC AG KONV. EBITDA is −7.90 M EUR, and current EBITDA margin is −2.60 K%. See more stats in 4 SC AG KONV. financial statements.